VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 60 filers reported holding VERA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $74,655,967 | -28.8% | 5,445,366 | -16.7% | 0.01% | -33.3% |
| Q2 2023 | $104,895,739 | +16.6% | 6,535,560 | -43.6% | 0.01% | +125.0% |
| Q1 2023 | $89,957,940 | +12.1% | 11,592,518 | +179.4% | 0.00% | -50.0% |
| Q4 2022 | $80,276,301 | -7.1% | 4,148,646 | +2.3% | 0.01% | -11.1% |
| Q3 2022 | $86,440,000 | +58.2% | 4,056,341 | +1.0% | 0.01% | +80.0% |
| Q2 2022 | $54,648,000 | -42.0% | 4,015,351 | +0.1% | 0.01% | -37.5% |
| Q1 2022 | $94,243,000 | +12.1% | 4,012,030 | +27.6% | 0.01% | +33.3% |
| Q4 2021 | $84,040,000 | +59.9% | 3,145,202 | +0.2% | 0.01% | +50.0% |
| Q3 2021 | $52,571,000 | +36.6% | 3,139,402 | +0.5% | 0.00% | +33.3% |
| Q2 2021 | $38,475,000 | – | 3,122,512 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,960,231 | $57,280,470 | 18.66% |
| Kynam Capital Management, LP | 1,409,098 | $27,266,046 | 4.18% |
| Sofinnova Investments, Inc. | 3,181,442 | $61,560,903 | 3.65% |
| Octagon Capital Advisors LP | 665,156 | $12,870,769 | 2.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 281,257 | $5,428,260 | 1.68% |
| Vivo Capital, LLC | 400,666 | $7,753 | 0.89% |
| Eversept Partners, LP | 411,308 | $7,958,810 | 0.70% |
| Logos Global Management LP | 285,000 | $5,514,750 | 0.65% |
| Alphabet Inc. | 301,580 | $5,835,573 | 0.34% |
| CARNEGIE MELLON UNIVERSITY | 16,060 | $310,761 | 0.17% |